多糖类生化药物的质控策略与质控技术研究进展

王悦, 范慧红

中国药学杂志 ›› 2021, Vol. 56 ›› Issue (1) : 8-12.

PDF(994 KB)
中国药学杂志
PDF(994 KB)
中国药学杂志 ›› 2021, Vol. 56 ›› Issue (1) : 8-12. DOI: 10.11669/cpj.2021.01.002
综述

多糖类生化药物的质控策略与质控技术研究进展

  • 王悦, 范慧红*
作者信息 +

Quality Control Strategies and Research Progress in Quality Control Technology of Polysaccharide Biochemical Drugs

  • WANG Yue, FAN Hui-hong*
Author information +
文章历史 +

摘要

对近年来多糖类生化药物质量控制技术和研究做整理分析。查阅近年来的国内外文献和实际工作实例,进行全面综合、整理和归纳。多糖药物质量控制难度较大,多糖质量控制应从定性、定量和安全性3个方面展开,可应用多角度激光光散射技术、离子色谱技术、液相色谱技术、核磁共振技术及红外光谱技术等多种技术和方法,对多糖药物理化性质、相对分子质量分布、糖组成与糖结构、含量、杂质控制及安全性检查项目等方面进行全面控制。

Abstract

To analyze the quality control technologies and research of polysaccharides in recent years. By searching the domestic and international literatures and practical experiences in recent years, a comprehensive integrated progress was collated and induced. Polysaccharide drugs have complex structures and their quality control is difficult. The quality control of polysaccharides should be carried out from three aspects: qualitive test, quantitative test, and safety test. Various technologies and methods such as infrared spectroscopy technology, multi-angle laser light scattering, ion chromatography, liquid chromatography, and nuclear magnetic resonance techniques should be used comprehensively to control the physical properties, molecular weight distribution, sugar composition and sugar structure, content, impurity control, and safety of polysaccharide drugs.

关键词

多糖类药物 / 检测方法 / 质量控制

Key words

polysaccharide / detection method / quality control

引用本文

EndNote

Ris (Procite)

Bibtex

导出引用
王悦, 范慧红. 多糖类生化药物的质控策略与质控技术研究进展[J]. 中国药学杂志, 2021, 56(1): 8-12 https://doi.org/10.11669/cpj.2021.01.002
WANG Yue, FAN Hui-hong. Quality Control Strategies and Research Progress in Quality Control Technology of Polysaccharide Biochemical Drugs[J]. Chinese Pharmaceutical Journal, 2021, 56(1): 8-12 https://doi.org/10.11669/cpj.2021.01.002
中图分类号： R917   

参考文献

[1] XIAO Z Q. Studies advances on quality control of polysaccharide from traditional Chinese medicine[J]. Chin Med Her(中国医药导报), 2015, 12(4):159-164.
[2] CHEN W X, WEI X M, WANG C H. Inhibitory effect of lentinan on tumor growth in thyroid cancer-bearing mice[J]. Chin J Clin Pharmacol(中国临床药理学杂志), 2019, 35(22):2875-2877.
[3] FU Y J, GAO X, TIAN Z, et al. Research progress on immunomodulatory ettects of lentinan on tumor microenvironment[J]. Drugs & Clin(现代药物与临床), 2019, 34(9):2870-2875.
[4] WANG W S, XU Y Y, SHI L R, et al. Research progress in chondroitinase from marine bacteria[J]. Chin Bull Life Sci(生命科学), 2019, 31(9):894-901.
[5] CHEN S, SHI J. The quality control of low molecular weight heparin[J]. Chin J New Drugs(中国新药杂志), 2018, 27(3):285-289.
[6] WANG Y, LI J, LIAO H M, et al. Capillary electrophoresis determination of impurities inheparin sodium injection[J]. Chin J Pharm Anal(药物分析杂志), 2011, 31(6):1119-1122.
[7] MARTINEAU E, EL KHANTACHE K, PUPIER M, et al. Non-linear effects in quantitative 2D NMR of polysaccharides: pitfalls and how to avoid them[J]. J Pharm Biomed Anal, 2015, 108:78-85.
[8] ZHAO Z Q, LIU X G, NIU X Z, et al. Determination of L-fucose content in polysaccharide extracted from Laminaria japonica using capillary gas chromatography[J]. Mar Sci(海洋科学), 2004, 28(10):10-13.
[9] CHEONG K L, WU D T, ZHAO J, et al. A rapid and accurate method for the quantitative estimation of natural polysaccharides and their fractions using high performance size exclusion chromatography coupled with multi-angle laser light scattering and refractive index detector[J]. J Chromatogr A, 2015, 1400:98-106.
[10] SOMMERS C D, YE H, KOLINSKI R E, et al. Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns[J]. Anal Bioanal Chem, 2011, 401(8):2445-2454.
[11] REN L P, YU H Z, SONG Y J. Enzymolysis-HPLC determination of the content of chondroitin sulfate sodium[J]. Chin J Pharm Anal(药物分析杂志), 2012, 32(7):1246-1248,1258.
[12] LI J, SONG Y J, HAN C X, et al. Quantification of free sugars in glycopeptide drugs by high performance anion exchange chromatography-pulsed amperometric detection[J]. Chin Pharm J(中国药学杂志), 2015, 50(17):1547-1552.
[13] XUE Y T, WU J, ZHAO X, et al. Determination of molecular weight and its distribution of propylene glycol alginate sodium sulfate(PSS)[J]. Chin J Mar Drugs(中国海洋药物), 2014, 33(2):1-5.
[14] SONG Y J, FAN H H. The second international collaborative study on molecular weight of heparin sodium reference standard[J]. Chin Pharm J(中国药学杂志), 2014, 49(23):2124-2127.
[15] SONG Y J, FAN H H. The first international collaborative study on molecular weight of heparin sodium reference standard[J]. Chin Pharm J(中国药学杂志), 2014, 49(22):2023-2026.
[16] SONG Y J, LI Y Y, FAN H H. Determination of molecular weight and molecular weight distribution of sodium hyaluronate and its preparations[J]. Chin J Pharm Anal(药物分析杂志), 2014, 34(8):1444-1448.
[17] ZHANG L Y, ZHAO X, CHEN H H. Advance in 1-phenyl-3-methyl-5-pyrazolone (PMP) derivatization analysis of carbohydrates[J]. J Instr Anal(分析测试学报), 2016, 35(3):367-372.
[18] JIANG H F, YU R L, WAN S B, et al. The application of carbohydrates pre-column pyrazolone labeling on marine carbohydrates analysis[J]. Chin J Mar Drugs(中国海洋药物), 2017, 36(2):91-96.
[19] ZHANG Q W, ZHENG Q. Advances in derivatization for the analysis of sialic acids by chromatography and/or mass spectrometry[J]. Chin J Chrom(色谱), 2019, 37(12):1261-1267.
[20] LIU Y J, XIAO L, LUO L M, et al. Determinaion of free sugars in Rhizoma Polygonati Odorati by silanization GC/MS[J]. J Int Pharm Res(国际药学研究杂志), 2018, 4(6):472-478.
[21] CHEN X X, LU J, LIU L, et al. Comparative analysis of oligosaccharides in milk based on two different derivatization methods by HPLC-tandem mass spectrometry[J]. Food Sci(食品科学), 2017, 38(10):162-167.
[22] KAN W N, LIU X F, YANG H W, et al. Determination of monosaccharide composition in gastric mucin polysaccharide by high performance ion exchange chromatography[J]. Drug Stand China(中国药品标准), 2019, 20(5):391-394.
[23] WANG Y, LI J, FAN H H. Determination of combined and free formaldehyde in cross-linked hyaluronate injection by high performance liquid chromatography with pre-column derivatization[J]. Chin Pharm J(中国药学杂志), 2016, 51(5):400-403.
[24] ZHU H, LV Y J, HAN X W. Comparison of structural characteristics and anticoagulation activity of enoxaparin sodium with different degree of 1,6-anhydro derivatives[J]. Acta Pharm Sin(药学学报), 2014, 49(7):1049-1053.
[25] LI D Y, CHI L Q, JIN L, et al. Mapping of low molecular weight heparins using reversed phase ion pair liquid chromatography-mass spectrometry[J]. Carbohyd Polym, 2014, 99:339-344.
[26] SHIROMA R, UECHI S, TAWATA S, et al. Isolation and characterization of alginate from Hizikia fusiformis and preparation of its oligosaccharides[J]. J Appl Glycosci, 2007, 54(2):85-90.
[27] LANGERSLAY D J, URSO E, GARDINI C, et al. Reversed-phase ion-pair ultra-high-performance-liquid chromatography-mass spectrometry for fingerprinting low-molecular-weight heparins[J]. J Chrom A, 2013, 1292:201-210.
[28] KING J T, DESAI U R. A capillary electrophoretic method for fingerprinting low molecular weight heparins[J]. Anal Biochem, 2008, 380(2):229-234.
[29] WANG Y, LI J, LI Y Y, et al. SAX-HPLC for 1,6-anhydro derivatives quantification of enoxaparin sodium [J]. Chin Pharm J(中国药学杂志), 2014, 49(16):1461-1466.
[30] WESTPHAL M, JAMES M F, KOZEK L S, et al. Hydroxyethyl starches: different products—different effects[J]. Anesthesiology, 2009, 111(1):187-202.
[31] JI C F, YUE L. Review on chemistry and anti-tumor effect of lentinan [J]. Chin Pharm J(中国药学杂志), 2013, 48(8):1536-1539.
[32] ZHAO X M, WANG Y, FAN H H. Overview of the quality study on hydroxyethyl starches [J]. Chin Pharm J(中国药学杂志), 2018, 53(13):1047-1501.
[33] TREIB J, BARON J F, GRAUER M T, et al. An international view of hydroxyethyl starches[J]. Intersive Care Med, 1999, 25(3):258-268.
[34] LI G Y, YANG B, LI L Y, et al. Analysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry[J]. Anal Biochem, 2014, 455(2):3-9.
[35] ALEKESEEVA A, CASU B, CASSINELLIi G, et al. Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments[J]. Anal Bioanal Chem, 2014, 406(1):249-265.
[36] VERALDI N, GUERRINI M, URSO E, et al. Fine structural characterization of sulodexide?[J]. Pharm Biomed Anal, 2018,156:67-79.
[37] DESAI U R, LINHARDT R J. Molecular weight of low molecular weight heparins by13C nuclear magnetic resonance spectroscopy[J]. Carbohydr Res, 1994, 255:193-212.
[38] MAURI L, MARINOZZI M, PHATAK N, et al. 1D and 2D-HSQC NMR: two methods to distinguish and characterize heparin from different animal and tissue sources[J]. Front Med (Lausanne), 2019, 6:142.
[39] ZHOU G Y, LEE H, HSU K J, et al. Three-dimensional structural imaging of starch granules by second-harmonic generation circular dichroism[J]. J Micros, 2014, 253(3):183-190.
[40] HERNANDEZ C P, MANSEL B W, LEIS A, et al. Structural analysis of polysaccharide networks by transmission electron microscopy: comparison with small-angle X-ray scattering[J]. Biomacromolecules, 2018, 19(3):989-995.
[41] LI J, FAN H H. Determination of the activity of anti-FXa and anti-FIIa of heparin by micro-chromogenic substrate methods [J]. Chin J Biochem Pharm(中国生化药物杂志), 2010, 31(1):45-47.
[42] LI J, WANG Y, AN H H. USP heparin protein impurities round robin study[J]. Chin J Pharm Anal(药物分析杂志), 2014, 34(2):301-305.
[43] WANG Y, LI J, FAN H H. Round robin study on methods for detection of residual nucleotidesin heparin[J]. Chin J Pharm Anal(药物分析杂志), 2013, 33(10):168-173.
[44] LI J, FAN H H. Determination of the free and linked sulfate content of heparin and heprin-like materials[J]. Chin J Pharm Anal(药物分析杂志), 2010, 30(3):452-455.
[45] HAN C X, LIANG L N, FAN H H. Determination of nitrite in dalteparin sodium by ion chromatography[J]. Chin J Pharm Anal(药物分析杂志), 2011, 31(11):2171-2173.
[46] WANG Y, LI J, FAN H H. Determination of residual cross-linker vinyl sulfone in sodium hyaluronate injection[J]. Chin J Biochem Pharm(中国生化药物杂志), 2014, 34(4):171-174.
[47] WANG Y, LI J, LI Y Y, et al. Determination of residual N,N-dimethylformamide (DMF) in enoxaparin sodium[J]. Chin J Biochem Pharm(中国生化药物杂志), 2014, 34(6):171-173.

基金

国家重大新药创制课题资助(2015ZX09303001);海洋药物国家重点实验室开放性课题资助(LMDBKF201806)
PDF(994 KB)

Accesses

Citation

Detail
段落导航
相关文章

/

〈 〉